Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 446

1.

Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.

Kleer CG, Giordano TJ, Braun T, Oberman HA.

Mod Pathol. 2001 Mar;14(3):185-90.

2.

Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.

Shpitz B, Bomstein Y, Sternberg A, Klein E, Tiomkin V, Kaufman A, Groisman G, Bernheim J.

J Surg Oncol. 2002 Feb;79(2):86-92.

PMID:
11815995
3.
4.

Recurrent phyllodes tumours of the breast: pathological features and clinical implications.

Tan EY, Tan PH, Yong WS, Wong HB, Ho GH, Yeo AW, Wong CY.

ANZ J Surg. 2006 Jun;76(6):476-80. Erratum in: ANZ J Surg. 2006 Oct;76(10):956. Hoon, Tan Puay [corrected to Tan, Puay Hoon]; Hui, Ho G [corrected to Ho, Gay Hui].

PMID:
16768772
5.

p53 protein expression and gene mutation in phyllodes tumors of the breast.

Gatalica Z, Finkelstein S, Lucio E, Tawfik O, Palazzo J, Hightower B, Eyzaguirre E.

Pathol Res Pract. 2001;197(3):183-7.

PMID:
11314782
6.

Phyllodes tumour: cytologic and histologic presentation of 22 cases, and immunohistochemical demonstration of p53.

Shabalova IP, Chemeris GJ, Ermilova VD, Rodionova LM, Pavlikova NA, Syrjänen KJ.

Cytopathology. 1997 Jun;8(3):177-87.

PMID:
9202893
7.

p53 and Ki-67 expression as prognostic factors in cystosarcoma phyllodes.

Erhan Y, Zekioglu O, Ersoy O, Tugan D, Aydede H, Sakarya A, Kapkaç M, Ozdemir N, Ozbal O, Erhan Y.

Breast J. 2002 Jan-Feb;8(1):38-44.

PMID:
11856160
8.

Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast.

Chan YJ, Chen BF, Chang CL, Yang TL, Fan CC.

J Chin Med Assoc. 2004 Jan;67(1):3-8.

PMID:
15077883
9.

Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma.

Yang P, Hirose T, Hasegawa T, Seki K, Sano T, Hizawa K.

Cancer. 1995 Aug 15;76(4):618-25.

10.

Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.

Kucuk U, Bayol U, Pala EE, Cumurcu S.

Indian J Pathol Microbiol. 2013 Apr-Jun;56(2):129-34. doi: 10.4103/0377-4929.118690.

11.

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.

Yonemori K, Hasegawa T, Shimizu C, Shibata T, Matsumoto K, Kouno T, Ando M, Katsumata N, Fujiwara Y.

Pathol Res Pract. 2006;202(10):705-12. Epub 2006 Aug 2.

PMID:
16889904
12.

Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.

Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA, Lewis JE.

Mod Pathol. 2003 Dec;16(12):1265-72.

13.

Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.

Umekita Y, Yoshida H.

Pathol Int. 1999 Sep;49(9):807-10.

PMID:
10504552
15.

Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.

PMID:
18300793
16.

[Distinction between benign and malignant pheochromocytomas].

Liu TH, Chen YJ, Wu SF, Gao J, Jiang WJ, Lu ZH, Guan J, Wei SZ, Luo YF, Cao JL, Wan JW.

Zhonghua Bing Li Xue Za Zhi. 2004 Jun;33(3):198-202. Chinese.

PMID:
15256107
17.

Phyllodes tumor of the prostate: long-term followup study of 23 cases.

Bostwick DG, Hossain D, Qian J, Neumann RM, Yang P, Young RH, di Sant'agnese PA, Jones EC.

J Urol. 2004 Sep;172(3):894-9.

PMID:
15310992
18.

Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation.

Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG.

Am J Surg Pathol. 1998 Jul;22(7):779-94. Erratum in: Am J Surg Pathol 1999 Jan;23(1):136.

PMID:
9669341
19.

Evidence for transformation of fibroadenoma of the breast to malignant phyllodes tumor.

Hodges KB, Abdul-Karim FW, Wang M, Lopez-Beltran A, Montironi R, Easley S, Zhang S, Wang N, MacLennan GT, Cheng L.

Appl Immunohistochem Mol Morphol. 2009 Jul;17(4):345-50. doi: 10.1097/PAI.0b013e318194d992.

PMID:
19276971
20.

Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases.

Niezabitowski A, Lackowska B, Rys J, Kruczak A, Kowalska T, Mitus J, Reinfuss M, Markiewicz D.

Breast Cancer Res Treat. 2001 Jan;65(1):77-85.

PMID:
11245343
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk